Search research articles
Contact Us
Filters
Showing results (11-20 of 85) with videos related to
Page
of 9
Sort By:
Harefuah
|
May 1, 1970
[An unusual complication of treatment with diphenadion]
U Lewinski, U A Liberman, A De Vries
JAMA
|
May 17, 1971
Parkinsonism syndrome due to cephaloridine
U Mintz, U A Liberman, A de Vries
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1986
Receptor-positive hereditary resistance to 1,25-dihydroxyvitamin D: chromatography of hormone-receptor complexes on deoxyribonucleic acid-cellulose shows two classes of mutation
U A Liberman, C Eil, S J Marx
The Journal of Urology
|
March 1, 1982
Late appearance of parathyroid adenoma in a renal transplant recipient with multiple primary malignancies
A Belldegrun, C Servadio, I Nissenkorn, et al.
FEBS Letters
|
March 25, 1985
Low affinity of the receptor for 1 alpha,25-dihydroxyvitamin D3 in the marmoset, a New World monkey
U A Liberman, D de Grange, S J Marx
In Vitro Cellular & Developmental Biology. Animal
|
April 1, 1997
1,25-dihydroxyvitamin D3 and agents that increase intracellular adenosine 3',5'-monophosphate synergistically inhibit fibroblast proliferation
N Saati, A Ravid, U A Liberman, et al.
Molecular and Cellular Endocrinology
|
October 1, 1993
1,25(OH)2D3 increases cytotoxicity and exocytosis in lymphokine-activated killer cells
A Ravid, R Koren, L Maron, et al.
The Journal of Nervous and Mental Disease
|
November 1, 1985
Penicillamine therapy for schizophreniform psychosis in Wilson's disease
I Modai, L Karp, U A Liberman, et al.
Biochemical and Biophysical Research Communications
|
August 30, 1984
1,25-Dihydroxyvitamin D3 inhibits selectively the mitogenic stimulation of mouse medullary thymocytes
A Ravid, R Koren, A Novogrodsky, et al.
Endocrinology
|
February 2, 1999
1,25-Dihydroxyvitamin D3 increases the growth-promoting activity of autocrine epidermal growth factor receptor ligands in keratinocytes
O Garach-Jehoshua, A Ravid, U A Liberman, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 85) with videos related to
Sort By:
Page
of 9
Harefuah
|
May 1, 1970
[An unusual complication of treatment with diphenadion]
U Lewinski, U A Liberman, A De Vries
JAMA
|
May 17, 1971
Parkinsonism syndrome due to cephaloridine
U Mintz, U A Liberman, A de Vries
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1986
Receptor-positive hereditary resistance to 1,25-dihydroxyvitamin D: chromatography of hormone-receptor complexes on deoxyribonucleic acid-cellulose shows two classes of mutation
U A Liberman, C Eil, S J Marx
The Journal of Urology
|
March 1, 1982
Late appearance of parathyroid adenoma in a renal transplant recipient with multiple primary malignancies
A Belldegrun, C Servadio, I Nissenkorn, et al.
FEBS Letters
|
March 25, 1985
Low affinity of the receptor for 1 alpha,25-dihydroxyvitamin D3 in the marmoset, a New World monkey
U A Liberman, D de Grange, S J Marx
In Vitro Cellular & Developmental Biology. Animal
|
April 1, 1997
1,25-dihydroxyvitamin D3 and agents that increase intracellular adenosine 3',5'-monophosphate synergistically inhibit fibroblast proliferation
N Saati, A Ravid, U A Liberman, et al.
Molecular and Cellular Endocrinology
|
October 1, 1993
1,25(OH)2D3 increases cytotoxicity and exocytosis in lymphokine-activated killer cells
A Ravid, R Koren, L Maron, et al.
The Journal of Nervous and Mental Disease
|
November 1, 1985
Penicillamine therapy for schizophreniform psychosis in Wilson's disease
I Modai, L Karp, U A Liberman, et al.
Biochemical and Biophysical Research Communications
|
August 30, 1984
1,25-Dihydroxyvitamin D3 inhibits selectively the mitogenic stimulation of mouse medullary thymocytes
A Ravid, R Koren, A Novogrodsky, et al.
Endocrinology
|
February 2, 1999
1,25-Dihydroxyvitamin D3 increases the growth-promoting activity of autocrine epidermal growth factor receptor ligands in keratinocytes
O Garach-Jehoshua, A Ravid, U A Liberman, et al.
Page
of 9